BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15465914)

  • 1. Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.
    Sugie K; Jeon MS; Grey HM
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14859-64. PubMed ID: 15465914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
    Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
    J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAZF is required for activation of naive CD4 T cells by TCR triggering.
    Takamori M; Hatano M; Arima M; Sakamoto A; Fujimura L; Hartatik T; Kuriyama T; Tokuhisa T
    Int Immunol; 2004 Oct; 16(10):1439-49. PubMed ID: 15314041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.
    Yadav A; Pati S; Nyugen A; Barabitskaja O; Mondal P; Anderson M; Gallo RC; Huso DL; Reid W
    Virology; 2006 Sep; 353(2):357-65. PubMed ID: 16828835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway.
    Bueno C; Lemke CD; Criado G; Baroja ML; Ferguson SS; Rahman AK; Tsoukas CD; McCormick JK; Madrenas J
    Immunity; 2006 Jul; 25(1):67-78. PubMed ID: 16860758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells.
    Methi T; Ngai J; Vang T; Torgersen KM; Taskén K
    Eur J Immunol; 2007 Sep; 37(9):2539-48. PubMed ID: 17683112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
    Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
    Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-independent signal transduction through the T-cell receptor (TCR/CD3).
    Granja CB; Gozashti CS; Dasgupta JD
    Immunology; 1994 Nov; 83(3):414-9. PubMed ID: 7835966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Lck activity by CD4 and CD28 in the immunological synapse.
    Holdorf AD; Lee KH; Burack WR; Allen PM; Shaw AS
    Nat Immunol; 2002 Mar; 3(3):259-64. PubMed ID: 11828322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway.
    Ngai J; Methi T; Andressen KW; Levy FO; Torgersen KM; Vang T; Wettschureck N; Taskén K
    Eur J Immunol; 2008 Nov; 38(11):3208-18. PubMed ID: 18991294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck.
    Soldaini E; Wack A; D'Oro U; Nuti S; Ulivieri C; Baldari CT; Abrignani S
    Eur J Immunol; 2003 Feb; 33(2):455-64. PubMed ID: 12645944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
    Chemnitz JM; Driesen J; Classen S; Riley JL; Debey S; Beyer M; Popov A; Zander T; Schultze JL
    Cancer Res; 2006 Jan; 66(2):1114-22. PubMed ID: 16424048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7.
    Granum S; Sundvold-Gjerstad V; Dai KZ; Kolltveit KM; Hildebrand K; Huitfeldt HS; Lea T; Spurkland A
    BMC Immunol; 2006 Jul; 7():15. PubMed ID: 16839418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.